LAVA Therapeutics announced the appointment of Christy Oliger to its board of directors effective March 9, 2023. Oliger brings extensive commercial, portfolio management, and senior leadership experience to the role. Additionally, Stefan Luzi, Ph.D., will step down from his role on the LAVA Board. Most recently, Oliger served as senior vice president, Oncology Business Unit Head at Genentech, where she also held numerous senior leadership roles of increasing responsibility across a variety of therapeutic areas.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on LVTX:
- LAVA Therapeutics Announces Appointment of Christy J. Oliger to its Board of Directors
- Lava Therapeutics selloff on data unwarranted, says H.C. Wainwright
- Lava Therapeutics announces initial data from Phase 1/2a study of LAVA-1207
- LAVA Therapeutics Announces Initial Data from the Ongoing Phase 1/2a Clinical Trial of LAVA-1207 in Therapy Refractory mCRPC at the 2023 ASCO GU Symposium
- LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer
